Research programme: genetically modified NK cells - St. Jude Children's Research HospitalAlternative Names: Anti-cancer therapy - St Jude Children's Research Hospital
Latest Information Update: 20 Feb 2008
At a glance
- Originator St. Jude Childrens Research Hospital
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Acute lymphoblastic leukaemia
Most Recent Events
- 31 May 2005 Investigation in Acute lymphoblastic leukaemia in USA (unspecified route)